Michael A. Schlesinger insider trades: Ortho Clinical Diagnostics Holdings (OCDX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | OCDX | ↓ Sell | 88,043 | $18.77 | $1.7M | Direct | Apr 6, 2022 (2d) |
| Jan 3, 2022 | OCDX | ↓ Sell | 130,000 | $21.09 | $2.7M | Direct | Jan 5, 2022 (2d) |
| Oct 15, 2021 | OCDX | ↓ Sell | 75,464 | $19.73 | $1.5M | Direct | Oct 19, 2021 (4d) |
| Aug 18, 2021 | OCDX | ↓ Sell | 45,015 | $20.13 | $906K | Direct | Aug 18, 2021 (0d) |
| Aug 13, 2021 | OCDX | ↓ Sell | 84,985 | $19.80 | $1.7M | Direct | Aug 13, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael A. Schlesinger's insider trades
Michael A. Schlesinger is EVP, GC and Secretary at Ortho Clinical Diagnostics Holdings (OCDX). Since Aug 13, 2021, Michael has reported no open-market purchases and 5 sales worth $8.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OCDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.